source
- Scholar Rock removes Indiana manufacturing site from SMA drug application after FDA cites deficienciesScholar Rock, a Massachusetts biotech, announced it is withdrawing an Indiana manufacturing facility from its filing for a prospective spinal muscular atrophy (SMA) therapy. The decision follows a…
- States urged to use low-cost, scalable outreach for Medicaid enrollees facing 2027 eligibility changesStates must begin notifying Medicaid beneficiaries about upcoming eligibility changes by September, as required by the One Big Beautiful Bill Act of 2025. The changes, set to take effect in 2027, i…